StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Last viewed:
abus
Prices are updated after-hours
Sector
Health Technology
1
Industry
Biotechnology
1
Name
Arbutus Biopharma Corporation
1
Symbol
Abus
1
Agtc
1
Aktx
1
Aldx
1
Amrk
1
Amswa
1
Anix
1
Arkr
1
Auud
1
Avdl
1
Avro
1
Bbsi
1
Bcov
1
Bimi
1
Blbd
1
Blin
1
Blnk
1
Bnr
1
Boom
1
Bwmx
1
Caba
1
Cala
1
Calt
1
Camp
1
Cdtx
1
Cdxc
1
Cfrx
1
Chco
1
Clsd
1
Cmct
1
Cnob
1
Cpix
1
Crex
1
Ctrn
1
Cuen
1
Cutr
1
Cvgw
1
Cwbc
1
Cycc
1
Ebix
1
Edit
1
Edsa
1
Ekso
1
Enob
1
Eols
1
Fate
1
Fbms
1
Frbk
1
Ftek
1
Ftft
1
Geos
1
Glg
1
Glpg
1
Gsit
1
Gtec
1
Hafc
1
Hpk
1
Htht
1
Ichr
1
Iclk
1
Tags
Hepatitis
1
Injection
1
Venue
Nasdaq
1
Ipo Year
N::a
1
Country
United States
1
Sec Forms
10-k
1
10-k::a
1
10-q
1
3
1
4
1
424b5
1
8-k
1
Corresp
1
Ct Order
1
Def 14a
1
Defa14a
1
Effect
1
S-3
1
S-8
1
Sc 13g
1
Sc 13g::a
1
Upload
1
Sec Forms Date
2021 - 08 - 05
1
2021 - 07 - 14
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 06 - 07
1
2021 - 06 - 01
1
2021 - 05 - 05
1
2021 - 04 - 08
1
2021 - 04 - 01
1
2021 - 03 - 16
1
2021 - 03 - 04
1
2021 - 02 - 26
1
2021 - 02 - 17
1
2021 - 02 - 16
1
2021 - 02 - 12
1
2021 - 02 - 10
1
2021 - 02 - 01
1
2021 - 01 - 25
1
2020 - 12 - 16
1
2020 - 12 - 10
1
2020 - 11 - 16
1
2020 - 11 - 05
1
2020 - 10 - 22
1
2020 - 10 - 21
1
2020 - 09 - 25
1
2020 - 09 - 15
1
2020 - 09 - 03
1
2020 - 09 - 01
1
2020 - 08 - 28
1
2020 - 08 - 27
1
2020 - 08 - 10
1
2020 - 08 - 07
1
2020 - 07 - 27
1
2020 - 07 - 24
1
2020 - 07 - 23
1
2020 - 07 - 16
1
2020 - 06 - 24
1
2020 - 06 - 01
1
2020 - 05 - 18
1
2020 - 05 - 11
1
2020 - 04 - 24
1
2020 - 03 - 26
1
2020 - 03 - 06
1
2020 - 03 - 05
1
2020 - 02 - 19
1
2020 - 02 - 14
1
2020 - 02 - 10
1
2020 - 01 - 13
1
2020 - 01 - 10
1
2020 - 01 - 08
1
2019 - 12 - 27
1
2019 - 12 - 23
1
2019 - 12 - 09
1
2019 - 11 - 06
1
2019 - 11 - 05
1
2019 - 10 - 03
1
2019 - 08 - 26
1
2019 - 08 - 20
1
News In 15d
1
1
News In 30d
2
1
Created At
2020 - 11 - 27
1
Abus
Nasdaq
2020 - 01 - 10
Arbutus Biopharma Corporation
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
(
0.0%
1d)
(
6.0%
1m)
(
-8.7%
1y)
(
0.0%
2d)
(
0.0%
3d)
(
-9.6%
7d)
(
-20.51%
volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 491,808,625
http://www.arbutusbio.com
Sec Filling
|
Patents
| 80 employees
ABUS
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis
injection
add to watch list
Paper trade
email alert is off
Press-releases
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published:
2024-04-18
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
-9.59%
|
O:
-5.82%
H:
0.0%
C:
0.0%
first
report
update
financial
results
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published:
2024-04-04
(Crawled : 12:30)
- globenewswire.com
MRNA
|
News
S
|
$107.87
3.26%
3.16%
2.4M
|
Health Technology
|
3.21%
|
O:
1.46%
H:
3.2%
C:
-0.41%
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
5.18%
|
O:
16.73%
H:
6.14%
C:
2.39%
patent
construction
biopharma
ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published:
2024-03-20
(Crawled : 12:00)
- globenewswire.com
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
4.35%
|
O:
-1.58%
H:
3.05%
C:
2.41%
year
update
financial
results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published:
2024-03-18
(Crawled : 14:00)
- prnewswire.com
CVAC
|
$2.585
2.17%
2.13%
610K
|
Health Technology
|
-23.33%
|
O:
0.0%
H:
0.0%
C:
-2.73%
BNTX
|
News
|
$88.53
0.59%
0.59%
360K
|
Health Technology
|
-4.83%
|
O:
0.48%
H:
1.18%
C:
0.08%
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
0.76%
|
O:
0.38%
H:
0.38%
C:
-3.42%
report
genomic
market
Arbutus to Participate in Two Upcoming Investor Conferences
Published:
2024-03-08
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
-4.0%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published:
2024-03-08
(Crawled : 14:30)
- biospace.com/
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
-4.0%
|
O:
0.18%
H:
0.0%
C:
0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published:
2024-02-29
(Crawled : 12:30)
- globenewswire.com
ROIV
|
$10.935
3.16%
3.06%
5M
|
Manufacturing
|
-9.48%
|
O:
1.2%
H:
0.34%
C:
-3.46%
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
-9.28%
|
O:
-1.37%
H:
0.0%
C:
-2.44%
year
update
financial
results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published:
2024-02-15
(Crawled : 12:30)
- globenewswire.com
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
-9.74%
|
O:
0.85%
H:
0.0%
C:
-1.36%
report
year
update
financial
results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published:
2024-01-08
(Crawled : 13:00)
- globenewswire.com
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
9.54%
|
O:
3.32%
H:
3.21%
C:
-1.61%
update
financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published:
2023-11-09
(Crawled : 21:00)
- globenewswire.com
ABUS
|
$2.74
3.79%
3.65%
1.1M
|
Health Technology
|
46.67%
|
O:
1.67%
H:
0.0%
C:
-3.28%
hbv003
biopharma
collaboration
trial
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
380500
380500
0001447028-24-000029
4
2024-02-06
2024-02-01
Buy
A
95100
95100
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
403900
403900
0001447028-24-000028
4
2024-02-06
2024-02-02
Sell
S
4358
125542
0001447028-24-000028
4
2024-02-06
2024-02-01
Buy
A
101000
129900
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI
|
$11.975
1.87%
0.04%
140K
|
|
00:30
CTRN
P
29000
|
$22.25
0.14%
0.13%
100K
|
Retail Trade
|
22:00
CONN
|
$3.71
1.37%
1.35%
72K
|
Retail Trade
|
21:30
TGEN
P
6000
|
$0.6897
39.71%
2.3K
|
Utilities
|
18:30
CMTV
P
700
|
$15.74
17.43%
12K
|
Finance and Insurance
|
18:30
FNB
|
$13.63
2.17%
0.0%
2.5M
|
Finance
|
17:30
RMCF
|
$3.57
0.28%
2.8K
|
Consumer Non-Durables
|
20:10
12 months watchlist earnings calendar